Spark Biomedical, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
10
Active:1
Completed:6
Trial Phases
1 Phases
Not Applicable:8
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Not Applicable
8 (100.0%)tAN for First Responders
Not Applicable
Not yet recruiting
- Conditions
- Mental FatigueMental Stress
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- Spark Biomedical, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT07109349
- Locations
- 🇺🇸
Spark Biomedical - DECENTRALIZED STUDY, Dallas, Texas, United States
Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial
Not Applicable
Recruiting
- Conditions
- Heavy Menstrual Bleeding
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Spark Biomedical, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT06814028
- Locations
- 🇺🇸
Five Liters - DECENTRALIZED STUDY, Dallas, Texas, United States
Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder
Recruiting
- Conditions
- Opioid Use DisorderOpioid Withdrawal
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Spark Biomedical, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06487533
- Locations
- 🇺🇸
Hazelden Betty Ford Foundation, Center City, Minnesota, United States
🇺🇸Battelle Memorial Institute, Columbus, Ohio, United States
Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction
Not Applicable
Completed
- Conditions
- Acute Stress ReactionCognitive Performance
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Spark Biomedical, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT06390267
- Locations
- 🇺🇸
Battelle Memorial Institute, Columbus, Ohio, United States
Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study
Completed
- Conditions
- Opioid Use DisorderRelapse
- First Posted Date
- 2022-10-24
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Spark Biomedical, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05591703
- Locations
- 🇺🇸
Betty Ford Foundation, Rancho Mirage, California, United States
🇺🇸Hazelden Betty Ford Foundation, Plymouth, Minnesota, United States
- Prev
- 1
- 2
- Next
News
No news found